print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
06/11/2014 (Added to site)
Author(s): Wei, Z.; Zheng, S.; Wang, R.; Bu, X.; Ma, H.; Wu, Y.; Zhu, L.; Hu, Z.; Liang, Z.; Li, Z.

A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery

Journal: Lab on a Chip, 14/20 (2014), pp. 4093-4102
DOI: 10.1039/c4lc00800f
Request reprint  |  Tell your friend  | 

Abstract: In vivo electroporation is an appealing method to deliver nucleic acid into living tissues, but the clinical application of such a method was limited due to severe tissue damage and poor coverage of the tissue surface. Here we present the validation of a novel flexible microneedle array electrode (MNAE) chip, in which the microneedle array and the flexible substrate are integrated together to simultaneously facilitate low-voltage electroporation and accomplish good coverage of the tissue surface. The efficient delivery of both DNA and siRNA was demonstrated on mice. Upon penetrating the high-resistance stratum corneum, the electroporation voltage was reduced to about 35 V, which was generally recognized safe for humans. Also, a pathological analysis of the microneedle-electroporated tissues was carried out to thoroughly assess the skin damage, which is an important consideration in pre-clinical studies of electroporation devices. This MNAE constitutes a novel way of in vivo delivery of siRNA and DNA to certain tissues or organs with satisfactory efficiency and good adaptation to the tissue surface profile as well as minimum tissue damage, thus avoiding the disadvantages of existing electroporation methods.


Keywords: electroporation    gene delivery    lab-on-chip    microneedles   

Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: